PIK3CA and breast cancer: Overall, the GR metrics and cell viability results demonstrated that multi-node inhibition by gedatolisib exerted greater anti-proliferative and cytotoxic effects than single-node inhibition in BC cells, regardless of PIK3CA or PTEN status.